MedTrace Logo

LEC Proliferation in Vivo and In-vitro

NCT03857685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-03-16

No results posted yet for this study

Summary

Investigate the proliferative capacity of individual lens epithelium capsule specimens in vitro and correlate it to the risk of developing PCO

Conditions

  • Posterior Capsule Opacification

Interventions

PROCEDURE

In-vitro model

In-vitro model of posterior capsule opacification by culturing the lens capsule

Sponsors & Collaborators

  • Prim. Prof. Dr. Oliver Findl, MBA

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-05-01
Completion
2021-01-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857685 on ClinicalTrials.gov